MARCONI, Pierfrancesco
 Distribuzione geografica
Continente #
NA - Nord America 8.728
EU - Europa 6.375
AS - Asia 5.564
SA - Sud America 1.026
Continente sconosciuto - Info sul continente non disponibili 613
AF - Africa 148
OC - Oceania 4
Totale 22.458
Nazione #
US - Stati Uniti d'America 8.511
SG - Singapore 2.492
UA - Ucraina 1.241
IE - Irlanda 950
SE - Svezia 947
BR - Brasile 794
CN - Cina 754
RU - Federazione Russa 737
IT - Italia 723
HK - Hong Kong 686
VN - Vietnam 644
DE - Germania 494
FI - Finlandia 370
FR - Francia 320
GB - Regno Unito 228
KR - Corea 191
TR - Turchia 174
IN - India 127
BD - Bangladesh 116
CA - Canada 107
AR - Argentina 78
MX - Messico 55
PL - Polonia 55
PK - Pakistan 49
BE - Belgio 46
IQ - Iraq 45
RO - Romania 43
ZA - Sudafrica 43
EC - Ecuador 42
NL - Olanda 41
JP - Giappone 40
UZ - Uzbekistan 38
CH - Svizzera 37
CO - Colombia 33
ID - Indonesia 33
ES - Italia 30
AT - Austria 29
MA - Marocco 29
VE - Venezuela 22
CZ - Repubblica Ceca 21
SA - Arabia Saudita 21
PH - Filippine 19
LT - Lituania 18
MY - Malesia 18
JM - Giamaica 17
GR - Grecia 16
TN - Tunisia 16
CL - Cile 15
KE - Kenya 15
PY - Paraguay 14
IR - Iran 13
PE - Perù 13
AZ - Azerbaigian 11
JO - Giordania 11
LB - Libano 11
CR - Costa Rica 10
EU - Europa 10
KZ - Kazakistan 10
AE - Emirati Arabi Uniti 9
NP - Nepal 9
DO - Repubblica Dominicana 8
UY - Uruguay 8
AL - Albania 7
EG - Egitto 7
ET - Etiopia 7
BO - Bolivia 6
DZ - Algeria 6
IL - Israele 6
KG - Kirghizistan 6
BG - Bulgaria 5
LY - Libia 5
SK - Slovacchia (Repubblica Slovacca) 5
BH - Bahrain 4
CI - Costa d'Avorio 4
GT - Guatemala 4
TH - Thailandia 4
AM - Armenia 3
AO - Angola 3
KW - Kuwait 3
AU - Australia 2
DK - Danimarca 2
GD - Grenada 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
MM - Myanmar 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
SC - Seychelles 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
VC - Saint Vincent e Grenadine 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BW - Botswana 1
Totale 21.830
Città #
Singapore 1.773
Chandler 1.181
Dublin 949
San Mateo 726
San Jose 713
Hong Kong 683
Jacksonville 635
Ashburn 499
Boardman 318
Santa Clara 318
Dong Ket 310
Ann Arbor 286
Medford 228
Princeton 226
Moscow 215
Perugia 208
Beijing 203
Lauterbourg 199
Wilmington 193
Seoul 185
Des Moines 181
Munich 174
Los Angeles 136
Andover 132
Izmir 121
Ho Chi Minh City 113
New York 96
The Dalles 90
Helsinki 86
São Paulo 83
Altamura 80
Lawrence 77
Saint Petersburg 76
Piscataway 72
Hanoi 70
Woodbridge 65
Turku 55
Brussels 44
Norwalk 43
Dallas 40
Frankfurt am Main 40
Phoenix 39
Montreal 38
Tokyo 38
Bucharest 36
Orem 36
Chennai 35
Houston 35
Brooklyn 31
Warsaw 31
Toronto 30
London 28
Redmond 27
Rio de Janeiro 26
Belo Horizonte 25
Columbus 25
Shanghai 25
Stockholm 25
Johannesburg 24
Poplar 24
Atlanta 23
Rome 23
Auburn Hills 22
Boston 22
Falls Church 22
Tashkent 22
Amsterdam 21
Milan 21
Ankara 20
Baghdad 20
Da Nang 19
Chicago 18
Denver 18
Buffalo 17
Council Bluffs 17
Falkenstein 16
Manchester 16
San Francisco 16
Foligno 15
Mexico City 15
Redwood City 15
Tavernelle 15
Dearborn 14
Dhaka 14
Guayaquil 14
Mumbai 14
Ottawa 14
New Delhi 13
Quito 13
Salvador 13
Charlotte 12
Curitiba 12
Guarulhos 12
Porto Alegre 12
Ardabil 11
San Diego 11
San Paolo di Civitate 11
Guangzhou 10
Karachi 10
Ribeirão Preto 10
Totale 13.133
Nome #
Effetti dell’infezione intracellulare da streptococco di gruppo B sierotipo Ia nel macrofago 239
Activity inhibition of cytolytic lymphocytes by omeprazole. 191
Activation of cytokine genes during primary and anamnestic immune response to inactivated C. albicans 184
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 180
Local and systemic immune response to inactivated C. albicans in mice 172
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha. 169
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 161
D-mannose in serum as indicator of systemic candidiasis in an experimental model. 157
Attività immunoadiuvante della Candida albicans in topi singenici e allogenici inoculati con linfoma LSTRA da virus di Moloney. 157
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 156
Cytokine response to inactivated Candida albicans in mice 153
Group B Streptococcus induces apoptosis in macrophages 151
Experimental model of type IV Streptococcus agalactiae (Group B streptococcus) infection in mice with development of septic arthritis. 151
Palmitate lipotoxicity in enteric glial cells: Lipid remodeling and mitochondrial ROS are responsible for cyt c release outside mitochondria 148
Clostridium difficile toxin B induces senescence in enteric glial cells: A potential new mechanism of Clostridium difficile pathogenesis 147
Group B Streptococcus induces macrophage apoptosis by calpain activation. 145
Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine 144
Cytokine response to group B streptococcus infection in mice 144
Macrophage induced gelsolin in response to Group B Streptococcus (GBS) infection 143
Group B streptococcus (GBS) modifies macrophage phosphatidylserine metabolism during induction of apoptosis 142
Enteric glial cells are susceptible to Clostridium difficile toxin B 140
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 140
Regolazione redox dell'apoptosi di linfociti B umani. 138
Graft engineering for allogeneic haploidentical stem cell transplantation 138
Cytokine gene expression during in vivo induction of natural killer/lymphokine activated killer cells by inactivated C. albicans cells 138
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. 136
Cardiovascular and organ responses and adaptation responses to hypogravity in an experimental animal model 133
Group B streptococcus (GBS) causes macrophage PLA(2)s activation and modification of phosphatidylserine metabolism during induction of apoptosis 133
Attività adiuvante della Candida albicans inattivata nel topo. 133
[On the cytological aspects of 3 in-vitro stabilized cell lines from fibroma induced in hamsters with polyoma virus]. 127
Modulating the gene silencing: novel insights to overcame gene therapy major limitation also in orthopaedic applications. 124
Antioxidant systems and lymphocyte proliferation in the horse, sheep and dog 124
Antibody response to ATPC+ascites tumour in mice rendered resistant by intravenous inoculation of liver cells. 124
Comparison of passive hemagglutination with Turkey erythrocyte assay, enzyme-linked immunosorbent assay, and counterimmunoelectrophoresis assay for serological evaluation of tetanus immunity. 124
Absence of metabolic cross-correction in Tay-Sachs cells: implication in gene therapy 123
[Colony inhibition test (C.I.T.) and the cytotoxic adherence test (C.A.T.): some comparative data]. 123
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 123
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 122
Group B Streptococcus (GBS) disrupts by calpain activation the actin and microtubule cytoskeleton of macrophages 122
Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum? 122
[Immune response to a histocompatible murine lymphoma. Synergism with chemotherapy] 120
Confronto tra l'attività immunoadiuvante della Candida albicans e del BCG. In: Atti del XVIII Congresso Nazionale della Società Italiana di Microbiologia. Fiuggi Terme, 2-4 Giugno 1978, vol. II: 1029-1038, 1978. 120
In vitro effects of Meropenem and Imipenem/Cilastatin on some functions of human natural effector cells 119
Enhancement of lysosomal glycohydrolase activity in human primary B lymphocytes during spontaneous apoptosis 119
1980, Sulla condizione di protezione verso il tetano nei neonati. (Indagine sierologica materno-neonatale). 119
Citochine nella risposta immune primaria e secondaria verso la C. albicans inattivata 119
A murine model of systemic infection with serotype IV group B streptococcus. 118
Immunosuppressive effect of cyclosporin A on resistance to systemic infection with Candida albicans 118
Enteric glial cells counteract Clostridium difficile Toxin B through a NADPH oxidase/ROS/JNK/caspase-3 axis, without involving mitochondrial pathways 117
Clostridioides difficile toxin B alone and with pro-inflammatory cytokines induces apoptosis in enteric glial cells by activating three different signalling pathways mediated by caspases, calpains and cathepsin B 116
Anti-Candida albicans precipitating antibodies in the sera of surgery patients. 116
[The use of passive hemagglutination with turkey erythrocytes for the effective prevention of tetanus in wounded patients]. 116
Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall. 115
Local and systemic immune response to inactivated Candida Albicans in mice. 114
Omeprazole induces apoptosis in normal human polymorphonuclear leucocytes 113
[Some experimental data on the seroprophylaxis of tetanus]. 113
[Antitumor immunoadjuvant activity and the immunoregulatory mechanisms of yeasts and their components]. 112
Antibody-independent protection in mice against type Ia group B streptococcus lethal infection. 111
Correlazione fra la induzione nel topo della espressione genica di citochine da parte della C. albicans inattivata ed attivazione di cellule NK/LAK 111
Citochine infiammatorie in risposta alla C. albicans inattivata 111
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 111
[Behavior of cell lines transformed by polyoma virus maintained at high incubation temperature (+41 degrees C)]. 110
Cytokine gene expression during primary and anamnestic immune response to inactivated C. albicans 110
[Rejection and circulating antibodies. Experimental results with a mouse ascite tumor]. 109
Histone deacetylation in retroviral driven transgene silencing: role of TSA as a pharmacological support for gene therapy 108
[The adherence cytotoxic test]. 108
[Epidemiological study of trichomonas vaginitis in Umbria]. 108
A rapid objective immunofluorescence microassay. Application for detection of surface and intracellular antigens. 107
Attivazione sistemica nel topo di cellule NK/LAK mediante C. albicans inattivata in combinazione con interleuchina-2 ricombinante (rIL-2) 107
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 107
Cytotoxic synergism of Clostridioides difficile toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases 106
L’N-Acetil-L-cisteina inibisce l’apoptosi di linfociti B umani regolando l’attivazione di diverse vie di trasduzione del segnale 106
[Immunostimulation with inactivated Candida albicans and chemotherapy in murine lymphoma] 106
Involvement of mitogen-activated protein kinases in Group B Streptococcus-induced macrophage apoptosis 106
Comparazione di tecniche sierologiche per la valutazione dello stato di resistenza verso il tetano nella popolazione. 106
Fungicidal activity of Candida albicans-induced murine lymphokine-activated killer cells against C.albicans hyphae in vitro. 106
Is thiol supplementation for potentiang antioxidant defenses a harmless strategy? 105
[Natural resistance and induced resistance to ATPC + tumor in mice]. 105
Anti-candida antibodies in human serum. Detection and definition of Ig classes by a new elution technique. 105
[Hemagglutinating activity of Candida albicans culture extracts]. 105
Clostridium difficile Toxin b induces enteric glial cell death through ROS generation and activation of JNK 104
Antigen specificity and immunogenic capacity of 3m KCl cell extracts from ascites tumour ATPCplus. 103
Espressione di geni per le citochine ed attivazione di cellule NK/LAK da parte della C. albicans inattivata 103
Eventi immunologici precoci nella risposta immune alla C. albicans inattivata 103
Group B streptococcus (GBS) causes macrophage PLA2s activation and modification of phosphatidyl- serine metabolism during induction of apoptosis 103
Alcune notazioni tecniche sulla esecuzione dei tests per lo studio della immunità verso il tetano. P. Marconi, F. Bistoni, L. Tissi, L. Mosci, E. Cenci, G. Sbaraglia, M. Pitzurra. Ann. Sclavo, 22: 245-247, 1980. 103
Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates 102
Proinflammatory Cytokines: Possible Accomplices for the Systemic Effects of Clostridioides difficile Toxin B 102
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 101
Protection test and early antibody response to tetanus immunization. 101
[The serum protein picture in mice with ATPC ascites tumors studied by means of disk electrophoresis]. 101
Inibizione della attività NK da parte dell’omeprazolo 101
L’apoptosi dei macrofagi indotta dallo Streptococco di Gruppo B (GBS) è Ca2+-calpaine- dipendente 100
Gamma interferon-induced specific binding of tetanus toxin on the GG2EE macrophage cell line. 100
Omeprazole induces apoptosis in Jurkat cells 100
[Further study of immunopotentiation in experimental antiblastic therapy by inactivated yeasts and glucan]. 100
[Technic for studying antitetanus immunity]. 99
Modulating effect of Cyclophosphamide (CY) on host's resistance against Candida albicans (CA) infection. 98
Group B streptococci persist inside macrophages. 97
Induction of natural killer cell activity by inactivated Candida albicans in mice. 97
Totale 12.297
Categoria #
all - tutte 95.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.295


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.771 0 0 38 183 96 18 30 615 35 189 227 340
2022/20233.416 254 391 31 306 307 528 5 160 1.274 7 109 44
2023/20241.284 84 151 98 22 8 8 327 45 133 41 185 182
2024/20253.245 38 294 141 208 451 145 146 230 601 187 518 286
2025/20266.623 492 369 325 895 941 644 1.156 254 804 536 122 85
2026/2027446 120 171 155 0 0 0 0 0 0 0 0 0
Totale 22.458